Apyx Medical Corp Net Income (Loss) Available to Common Stockholders, Diluted
Apyx Medical Corp (APYX) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$6.56 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2024-08-08
- Apyx Medical Corp net income (loss) available to common stockholders, diluted for the quarter ending 2024-06-30 was -$6.56M.
- Apyx Medical Corp net income (loss) available to common stockholders, diluted for the quarter ending 2024-03-31 was -$7.58M.
- Apyx Medical Corp net income (loss) available to common stockholders, diluted for the quarter ending 2023-12-31 was -$9.61M.
- Apyx Medical Corp net income (loss) available to common stockholders, diluted for the quarter ending 2023-09-30 was -$4.63M.
- Apyx Medical Corp net income (loss) available to common stockholders, diluted for fiscal 2023 was -$18.71M.
- Apyx Medical Corp net income (loss) available to common stockholders, diluted for fiscal 2022 was -$23.18M.
- Apyx Medical Corp net income (loss) available to common stockholders, diluted for fiscal 2019 was -$19.71M, a 131.42% decline from fiscal 2018.
- Apyx Medical Corp net income (loss) available to common stockholders, diluted for fiscal 2018 was $62.72M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2024-06-30 | -$6.56M 10-Q · filed 2024-08-08 | -$14.13M 10-Q · filed 2024-08-08 | -$23.74M derived: sum of 3 quarters · filed 2024-08-08 | -$28.37M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2024-03-31 | -$7.58M 10-Q · filed 2024-05-09 | -$17.18M derived: sum of 2 quarters · filed 2024-05-09 | -$21.81M derived: sum of 3 quarters · filed 2024-05-09 | -$22.81M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-12-31 | -$9.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$14.24M derived: sum of 2 quarters · filed 2024-03-21 | -$15.23M derived: sum of 3 quarters · filed 2024-08-08 | -$18.71M 10-K · filed 2024-03-21 | |||
| 2023-09-30 | -$4.63M 10-Q · filed 2023-11-09 | -$5.62M derived: sum of 2 quarters · filed 2024-08-08 | -$9.11M 10-Q · filed 2023-11-09 | -$15.15M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-06-30 | -$994.00K 10-Q · filed 2024-08-08 | -$4.48M 10-Q · filed 2024-08-08 | -$10.53M derived: sum of 3 quarters · filed 2024-08-08 | -$16.29M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | -$3.48M 10-Q · filed 2024-05-09 | -$9.53M derived: sum of 2 quarters · filed 2024-05-09 | -$15.30M derived: sum of 3 quarters · filed 2024-05-09 | -$20.72M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | -$6.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$11.81M derived: sum of 2 quarters · filed 2024-03-21 | -$17.24M derived: sum of 3 quarters · filed 2024-03-21 | -$23.18M 10-K · filed 2024-03-21 | |||
| 2022-09-30 | -$5.76M 10-Q · filed 2023-11-09 | -$11.19M derived: sum of 2 quarters · filed 2023-11-09 | -$17.14M 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | -$5.43M 10-Q · filed 2023-08-11 | -$11.37M 10-Q · filed 2023-08-11 | |||||
| 2022-03-31 | -$5.95M 10-Q · filed 2023-05-11 | ||||||
| 2021-09-30 | -$4.22M 10-Q · filed 2022-11-10 | -$8.27M derived: sum of 2 quarters · filed 2022-11-10 | -$13.17M 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | -$4.05M 10-Q · filed 2022-08-11 | -$8.95M 10-Q · filed 2022-08-11 | |||||
| 2021-03-31 | -$4.90M 10-Q · filed 2022-05-12 | ||||||
| 2020-09-30 | -$3.73M 10-Q · filed 2021-11-12 | -$8.42M derived: sum of 2 quarters · filed 2021-11-12 | -$10.37M 10-Q · filed 2021-11-12 | ||||
| 2020-06-30 | -$4.69M 10-Q · filed 2021-08-12 | -$6.64M 10-Q · filed 2021-08-12 | |||||
| 2019-12-31 | -$19.71M 10-K · filed 2020-03-31 | ||||||
| 2019-06-30 | -$3.41M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2019-08-07 | -$9.02M 10-Q · filed 2019-08-07 | |||||
| 2019-03-31 | -$5.61M 10-Q/A · filed 2020-05-08 | -$4.68M 10-Q · filed 2019-05-08 | |||||
| 2018-12-31 | $62.72M 10-K · filed 2020-03-31 | $64.01M 10-K · filed 2019-03-14 | |||||
| 2018-06-30 | -$272.00K 10-Q · filed 2018-08-01 | -$1.21M 10-Q · filed 2019-08-07 | -$2.21M derived: sum of 3 quarters · filed 2020-05-08 | -$3.46M derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2018-03-31 | -$935.00K 10-Q/A · filed 2020-05-08 | -$1.94M derived: sum of 2 quarters · filed 2020-05-08 | -$3.19M derived: sum of 3 quarters · filed 2020-05-08 | -$4.50M derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2017-12-31 | -$1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | -$2.25M derived: sum of 2 quarters · filed 2020-03-31 | -$3.56M derived: sum of 3 quarters · filed 2020-03-31 | -$5.25M 10-K · filed 2020-03-31 | |||
| 2017-09-30 | -$1.25M 10-Q · filed 2017-11-03 | -$2.55M derived: sum of 2 quarters · filed 2018-08-01 | -$4.24M 10-Q · filed 2017-11-03 | -$4.91M derived: sum of 4 quarters · filed 2019-03-14 | |||
| 2017-06-30 | -$1.31M 10-Q · filed 2018-08-01 | -$2.99M 10-Q · filed 2018-08-01 | -$3.67M derived: sum of 3 quarters · filed 2019-03-14 | -$4.63M derived: sum of 4 quarters · filed 2019-03-14 | |||
| 2017-03-31 | -$1.77M 10-Q · filed 2018-05-15 | -$2.36M derived: sum of 2 quarters · filed 2019-03-14 | -$3.32M derived: sum of 3 quarters · filed 2019-03-14 | -$3.84M derived: sum of 4 quarters · filed 2019-03-14 | |||
| 2016-12-31 | -$586.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$1.55M derived: sum of 2 quarters · filed 2019-03-14 | -$2.07M derived: sum of 3 quarters · filed 2019-03-14 | -$4.01M 10-K · filed 2019-03-14 | |||
| 2016-09-30 | -$965.00K 10-Q · filed 2017-11-03 | -$964.00K 10-Q · filed 2016-10-27 | -$1.48M derived: sum of 2 quarters · filed 2017-11-03 | -$3.43M 10-Q · filed 2017-11-03 | -$4.83M derived: sum of 4 quarters · filed 2018-03-13 | ||
| 2016-06-30 | -$519.00K 10-Q · filed 2017-08-03 | -$560.00K 10-Q · filed 2016-08-02 | -$2.46M 10-Q · filed 2017-08-03 | -$2.59M 10-Q · filed 2016-08-02 | -$3.87M derived: sum of 3 quarters · filed 2018-03-13 | -$5.46M derived: sum of 4 quarters · filed 2018-03-13 | |
| 2016-03-31 | -$1.94M 10-Q · filed 2017-05-15 | -$3.35M derived: sum of 2 quarters · filed 2018-03-13 | -$4.94M derived: sum of 3 quarters · filed 2018-03-13 | -$6.43M derived: sum of 4 quarters · filed 2018-03-13 | |||
| 2015-12-31 | -$1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$2.99M derived: sum of 2 quarters · filed 2018-03-13 | -$4.49M derived: sum of 3 quarters · filed 2018-03-13 | $6.79M 10-K · filed 2018-03-13 | |||
| 2015-09-30 | -$1.59M 10-Q · filed 2016-10-27 | -$3.08M derived: sum of 2 quarters · filed 2016-10-27 | $8.19M 10-Q · filed 2016-10-27 | ||||
| 2015-06-30 | -$1.50M 10-Q · filed 2016-08-02 | $10.05M 10-Q · filed 2016-08-02 | |||||
| 2015-03-31 | $11.64M 10-Q · filed 2016-05-11 | ||||||
| 2014-12-31 | -$18.21M 10-K · filed 2017-03-10 | ||||||
| 2013-12-31 | -$6.99M 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |